StockData
Takeda Pharmaceutical Co Ltd logo

Takeda Pharmaceutical Co Ltd (TAK) stock

TAKNYSEPharmaceutical PreparationsAlso trades as TKPHF
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Mar 31, 2026Last filing: 20-F on Jun 17, 2026Score 5/30
$21.64+0.05 (+0.23%)

Close on Nov 17, 2026Market cap $74.58BP/E –Yield –

Takeda Pharmaceutical enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Takeda Pharmaceutical's enterprise value was $93.42B on Nov 11, 2026, against $72.34B a year earlier. Over the last 5 years it ranged from $65.20B to $93.78B, with a median of $75.16B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$93.42B+23.0%
2025Dec 31, 2025$75.95B+8.8%
2024Dec 31, 2024$69.78B-3.7%
2023Dec 29, 2023$72.47B-4.5%
2022Dec 30, 2022$75.89B+1.4%
2021Dec 31, 2021$74.87B-25.6%
2020Dec 31, 2020$100.60B-7.1%
2019Dec 31, 2019$108.25B+225.9%
2018Dec 31, 2018$33.22B-21.2%
2017Dec 29, 2017$42.15B–

More Takeda Pharmaceutical figures

See a number that looks wrong?